Journal: The Journal of Biological Chemistry
Article Title: The Translocon Sec61? Localized in the Inner Nuclear Membrane Transports Membrane-embedded EGF Receptor to the Nucleus *
doi: 10.1074/jbc.M110.158659
Figure Lengend Snippet: EGFR associates with the translocon Sec61β in the INM. A, A431 cells maintained in a serum-starved medium for 24 h were treated with EGF followed by cellular fractionation. B, proteins in A were immunoprecipitated (IP) using anti-EGFR followed by immunoblotting. C, INM portions had undetectable cross-contamination with the process of cellular fractionation. MDA-MB-468 cells maintained in a serum-starved medium for 24 h were treated with EGF in a different period followed by cellular fractionation as described in the legend for Fig. 2 and subjected to immunoblotting with the indicated antibodies. The relative density of the INM-EGFR immunoblotting at zero time was defined as 1 after subtraction of the background by using the ImageJ software program (version 1.38x) to quantify the signals. The EGFR blotting of the left panel has five times shorter exposure than that of right panel. D, EGFR associated with Sec61β in the INM portions but not the NP portions in response to EGF in a time-dependent manner. The purified INM and NP portions in C were immunoprecipitated using the indicated antibodies (Abs.) followed by immunoblotting. E, co-localization of EGFR and Sec61β in the INM was analyzed using immuno-EM. An ultrathin section of MDA-MB-468 cells treated with EGF was immunostained with EGFR (goat anti-mouse IgG, 1-nm gold particles, arrows) and Sec61β (goat anti-rabbit IgG, 10-nm gold particles, arrowheads). Bar, 1 μm. PM, plasma membrane; Cy, cytoplasm.
Article Snippet: The gold particles labeling Sec61β were confirmed by two different specific primary anti-Sec61β antibodies obtained from Upstate Biotech Millipore ( supplemental Fig. S5, upper inset panel , arrows ) and from Proteintech ( supplemental Fig. S5, lower panel , arrows ), which demonstrated that the localization of Sec61β was primarily detectable in the INM.
Techniques: Cell Fractionation, Immunoprecipitation, Western Blot, Software, Purification, Clinical Proteomics, Membrane